There was a lot of excitement when Tepezza became the first drug approved for the treatment of thyroid eye disease in January ...

S.BIOMEDICS reported that TED-A9, an investigational cell therapy for Parkinson's disease, showed positive data during the Phase 1/2a trial.

Viridian Therapeutics Inc. (NASDAQ:VRDN) is one of the best low priced pharma stocks to buy now. Earlier on May 20, Viridian ...

Conservative Sen. Ted Cruz (Texas) on Monday pointed to what he called the “anti-capitalist” views of the 26-year-old man named as a person of interest in the investigation of the shooting ...

Viridian is also advancing VRDN-003 as a potential best-in-class subcutaneous therapy for the treatment of TED, including two ongoing global phase 3 pivotal clinical trials, REVEAL-1 and REVEAL-2 ...

Veligrotug demonstrated significant improvements in proptosis, diplopia, and clinical activity score among patients with active thyroid eye disease.

Viridian Therapeutics Announces Positive Long-Term Durability Data from the Veligrotug Phase 3 THRIVE Clinical Trial in Patients with Active Thyroid Eye Disease (TED) - 70% of patients treated ...

Ted Cruz calls suspected UnitedHealthcare CEO shooter proof leftism is a “mental disease” Commenting on Luigi Mangione's embrace of climate-change causes, Cruz says support from "leftists" has ...